Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Airway MedixWAR:AWM -1.14%19 Equity-to-Asset is -0.82 as of Mar. 2026. GuruFocus rates WAR:AWM with a GF Score™ of 19/100. The stock has 9 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Airway Medix ranks worse than 96.13% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Airway Medix's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł-10.13 Mil. Airway Medix's Total Assets for the quarter that ended in Mar. 2026 was zł12.33 Mil.
Therefore, Airway Medix's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was -0.82.
The historical rank and industry rank for Airway Medix's Equity-to-Asset or its related term are showing as below:
WAR:AWM'
s Equity-to-Asset Range Over the Past 10 Years
Min: -21.75 Med: 0.55 Max: 0.89
Current: -0.82
During the past 11 years, the highest Equity to Asset Ratio of Airway Medix was 0.89. The lowest was -21.75. And the median was 0.55.
WAR:AWM's Equity-to-Asset is ranked worse than 96.13% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs WAR:AWM: -0.82
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Airway Medix Equity-to-Asset Related Terms
Airway Medix Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Airway Medix's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:AWM vs ISRG, BDX, RMD: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Airway Medix's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Airway Medix Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Airway Medix's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Airway Medix's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Airway Medix's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Airway Medix (WAR:AWM) has a Equity-to-Asset of -0.82 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Airway Medix and its competitors. According to the industry distribution chart, Airway Medix ranks #819 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 96.1%.
Is Airway Medix's Equity-to-Asset too high?
Airway Medix's current Equity-to-Asset is -0.82. Based on the distribution chart, Airway Medix ranks #819 out of 852 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Airway Medix has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Airway Medix's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Airway Medix ranks #819 out of 852 companies for Equity-to-Asset. This places Airway Medix in the lower half of its industry. The industry median Equity-to-Asset is 0.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Airway Medix and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Airway Medix's current Equity-to-Asset is -0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Airway Medix stock overvalued right now?
Airway Medix (WAR:AWM) has a current Equity-to-Asset of -0.82. The current Equity-to-Asset is -0.82. Airway Medix's overall GF Score™ is 19/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Airway Medix (WAR:AWM), the current Equity-to-Asset is -0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
19GF Score
Get the complete analysis for WAR:AWM
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:AWM has been successfully added to your 
